Skip to content

Safety, Acute Efficacy and Long-Term Effectiveness of the Phoenix Atherectomy System in Patients with Lower Limb Ischemia. A Prospective Study.

Safety, Acute Efficacy and Long-Term Effectiveness of the Phoenix Atherectomy System in Patients with Lower Limb Ischemia. A Prospective Study. - Phoenix-Weinheim

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00016708
Enrollment
500
Registered
2019-02-11
Start date
2017-08-26
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I70.25

Interventions

Group 1: Patients undergoing phoenix atherectomy for clinical reasons.

Sponsors

GRN Klinik Weinheim
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: PAD patients with claudication or critical limb ischemia.

Exclusion criteria

Exclusion criteria: 1. Fontaine Stages I or IIa. 2. Acute limb-threatening ischemia 3. Candidates requiring surgical revascularization 4. Creatinine clearance <30 mL/min. 5. Platelet count <100x109/L. 6. Anemia with Hb<10.0 g/dL. 7. History of or condition associated with increased bleeding Risk.

Design outcomes

Primary

MeasureTime frame
1. Procedural success (i.e. residual stenosis <25% after atherectomy and adjacent treatment), 2. clinical success (i.e. achievement of at least one grade improvement in the Rutherford class at 1 month of follow-up) and 3. Long-term clinical success (i.e. achievement of at least one grade improvement in the Rutherford class at 1-5 years of follow-up).

Secondary

MeasureTime frame
1. safety endpoints such as perforation, dissection or embolization during the atherectomy procedure. 2. Clinically driven target vessel revascularization (TVR) at 1 month of follow-up. 3. Long-term clinically driven target vessel revascularization (TVR) at 1-5 yrs. of follow-up.

Countries

Germany

Contacts

Public ContactGrigorios Korosoglou

GRN Klinik Weinheim

grigorios.korosoglou@grn.de00496201894160

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 26, 2026